Cargando…

Tumour necrosis factor, interferon-gamma and interleukins as predictive markers of antiprogrammed cell-death protein-1 treatment in advanced non-small cell lung cancer: a pragmatic approach in clinical practice

BACKGROUND: The emergence of novel antiprogrammed cell death protein-1 (PD-1) inhibitors in non-small cell lung cancers (NSCLC) has revolutionized the therapeutic landscape of this disease. Although overall survival (OS) has improved in the first- and second-line therapy settings for advanced NSCLC,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boutsikou, Efimia, Domvri, Kalliopi, Hardavella, Georgia, Tsiouda, Dora, Zarogoulidis, Konstantinos, Kontakiotis, Theodoros
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5894896/ https://www.ncbi.nlm.nih.gov/pubmed/29662549 http://dx.doi.org/10.1177/1758835918768238

Ejemplares similares

Predictive Value of 99MTC-hynic-toc Scintigraphy in Lung Neuroendocrine Tumor Diagnosis
por: Boutsikou, Efimia, et al.
Publicado: (2019)

New dilemmas in small-cell lung cancer TNM clinical staging
por: Zarogoulidis, Konstantinos, et al.
Publicado: (2013)

Immunomodifiers in combination with conventional chemotherapy in small cell lung cancer: a Phase II, randomized study
por: Zarogoulidis, Konstantinos, et al.
Publicado: (2013)

BALF and BLOOD NK- cells in different stages of pulmonary sarcoidosis
por: Manika, Katerina, et al.
Publicado: (2021)

The role of second-line chemotherapy in small cell lung cancer: a retrospective analysis
por: Zarogoulidis, Konstantinos, et al.
Publicado: (2013)

Antiprogramed cell death‐1 therapy with microspheres for metastatic liver tumors
por: Kamimura, Hiroteru, et al.
Publicado: (2019)

A case of typical pulmonary carcinoid tumor treated with bronchoscopic therapy followed by lobectomy
por: Porpodis, Konstantinos, et al.
Publicado: (2012)

Docetaxel-carboplatin in combination with erlotinib and/or bevacizumab in patients with non-small cell lung cancer
por: Boutsikou, Eftimia, et al.
Publicado: (2013)

Safety and Efficacy of Suicide Gene Therapy with Adenosine Deaminase 5-Fluorocytosine Silmutaneously in in Vitro Cultures of Melanoma and Retinal Cell Lines
por: Sakkas, Antonios, et al.
Publicado: (2014)

Clinical, imaging and functional determinants of sarcoidosis phenotypes in a Greek population
por: Spyropoulos, Georgios, et al.
Publicado: (2022)

Prognostic Value of Serum Biomarkers in Patients with Idiopathic Pulmonary Fibrosis in Relation to Disease Progression
por: Domvri, Kalliopi, et al.
Publicado: (2023)

The epistemic culture in an online citizen science project: Programs, antiprograms and epistemic subjects
por: Kasperowski, Dick, et al.
Publicado: (2018)

Circulating interleukin 6 during a continuous infusion of tumor necrosis factor and interferon gamma
Publicado: (1989)

Epidemiology of lung cancer in Northern Greece: An 18-year hospital-based cohort study focused on the differences between smokers and non-smokers
por: Domvri, Kalliopi, et al.
Publicado: (2020)

Molecular Targeted Drugs and Biomarkers in NSCLC, the Evolving Role of Individualized Therapy
por: Domvri, Kalliopi, et al.
Publicado: (2013)

Interleukin 12, interferon gamma, and tumor necrosis factor alpha are the key cytokines of the generalized Shwartzman reaction
Publicado: (1994)

Phase I study of the antiprogrammed cell death‐1 Ab spartalizumab (PDR001) in Japanese patients with advanced malignancies
por: Minami, Hironobu, et al.
Publicado: (2020)

A Multifactoral Analysis of 1452 Patients for Smoking Sensation. An Outpatient Lab Experience
por: Tsiouda, Theodora, et al.
Publicado: (2014)

Interferon gamma and interleukin 1, but not interferon alfa, inhibit rotavirus entry into human intestinal cell lines
por: Bass, DM
Publicado: (1997)

Early interleukin 12 production by macrophages in response to mycobacterial infection depends on interferon gamma and tumor necrosis factor alpha
Publicado: (1995)

Genetic Polymorphism of Tumor Necrosis Factor-Alpha, Interferon-Gamma and Interleukin-10 and Association With Risk of Mycobacterium Tuberculosis Infection
por: Adane, Gashaw, et al.
Publicado: (2021)

Recombinant interleukin 4 suppresses the production of interferon gamma by human mononuclear cells
Publicado: (1989)

Clinical Characteristics and Pharmacokinetics Change of Long-Term Responders to Antiprogrammed Cell Death Protein 1 Inhibitor Among Patients With Advanced NSCLC
por: Jo, Hitomi, et al.
Publicado: (2023)

Interferon gamma inhibits interleukin 10 production by monocytes
Publicado: (1993)

Interleukin-1 beta, interferon-gamma, and tumor necrosis factor-alpha gene expression in peripheral blood mononuclear cells of patients with coronary artery disease
por: Enayati, Samaneh, et al.
Publicado: (2015)

Methylprednisolone inhibits interleukin-17 and interferon-gamma expression by both naive and primed T cells
por: Momčilović, Miljana, et al.
Publicado: (2008)

The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells
Publicado: (1996)

Enhanced Inhibitory Effect of DC-CIK Cells on Lung Adenocarcinoma via Anti-Tim-3 Antibody and Antiprogrammed Cell Death-1 Antibody and Possible Mechanism
por: Zhou, Liang, et al.
Publicado: (2022)

Potential synergistic effect of phosphodiesterase inhibitors with chemotherapy in lung cancer
por: Domvri, Kalliopi, et al.
Publicado: (2017)

Subclavian thrombosis in a patient with advanced lung cancer: a case report
por: Zarogoulidis, Paul, et al.
Publicado: (2011)

Orbital Metastases as the First Manifestation of Lung Adenocarcinoma
por: Zarogoulidis, Paul, et al.
Publicado: (2011)

Anti-inflammatory cytokines in asthma and allergy: interleukin-10, interleukin-12, interferon-gamma.
por: Chung, F
Publicado: (2001)

Killer-cell inhibitory receptors, CD158a/b, are upregulated by interleukin-2, but not interferon-gamma or interleukin-4.
por: Kogure, T, et al.
Publicado: (1999)

Expression of interleukin 2 receptors and binding of interleukin 2 by gamma interferon-induced human leukemic and normal monocytic cells
Publicado: (1985)

Inhaled chemotherapy in lung cancer: future concept of nanomedicine
por: Zarogoulidis, Paul, et al.
Publicado: (2012)

In vitro interleukin 4 and interferon-gamma production by mononuclear cells from atopic dermatitis patients
por: Well, Serge, et al.
Publicado: (1993)

Human tumour-associated NK cells secrete increased amounts of interferon-gamma and interleukin-4.
por: Lorenzen, J., et al.
Publicado: (1991)

Profiles of interferon-gamma and interleukin-2 in patients after allogeneic hematopoietic stem cell transplantation
por: Rybicka-Ramos, Malwina, et al.
Publicado: (2022)

Dysregulation of interleukin 4, interleukin 5, and interferon gamma gene expression in steroid-resistant asthma
Publicado: (1995)

Gamma interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin 1, and urokinase genes, which are controlled by short-lived repressors
Publicado: (1986)

Cannot write session to /tmp/vufind_sessions/sess_n62fnkoeqb6mgao6o0ckiamlej